Patient characteristic | Total | Fluoxetine | Placebo | P-value* |
---|---|---|---|---|
 | N = 34 (100%) | N = 18 (53%) | N = 16 (47%) |  |
Ethnicity, n (%) | Â | Â | Â | .75 |
White | 25 (73%) | 14 (78%) | 11 (19%) | Â |
African American | 6 (18%) | 3 (17%) | 3 (69%) | Â |
Other | 3 (9%) | 1 (5%) | 2 (12%) | Â |
Age (years), mean ± SD | 16.46 ± 1.08 | 16.55 ± 1.11 | 16.35 ± 1.08 | .61 |
Gender, n (%) | Â | Â | Â | .18 |
Female | 5 (15%) | 4 (22%) | 1 (6%) | Â |
Male | 29 (85%) | 14 (78%) | 15 (94%) | Â |
Current Depressive Disorder | ||||
MDDa | 29 (85.3%) | 15 (83.3%) | 14 (87.5%) | 1.0 |
Other Depressive Disorderb | 5 (14.7%) | 3 (16.7%) | 2 (12.5%) | .56 |
Age at onset of depression, mean ± SD | 11.41 ± 2.5 | 11.9 ± 2.7 | 10.8 ± 2.1 | .19 |
Length of depression, mean ± SD (weeks) | 213.1 ± 153.6 | 185.0 ± 168.3 | 244.7 ± 133.4 | .26 |
Current comorbid condition, n (%) | ||||
ADHDc | 11 (32.4%) | 6 (33%) | 5 (31.3%) | 1.0 |
Post Traumatic Stress Disorder | 2 (5.9%) | 1 (5.6%) | 1 (6.3%) | 1.0 |
Conduct Disorder | 2 (5.9%) | 0 (0%) | 2 (12.5%) | .21 |
Current SUD d,e | ||||
Alcohol | 13 (38.2%) | 7 (38.9%) | 6 (37.5) | 1.0 |
Alcohol Abuse | 10 (29.4%) | 5 (27.8%) | 5 (31.25%) | 1.0 |
Alcohol Dependence | 3 (8.8%) | 2 (11.1%) | 1 (6.25%) | Â |
Cannabis | 30 (88.2%) | 15 (83.3%) | 15 (93.8%) | .60 |
Cannabis Abuse | 16 (47%) | 9 (50.0%) | 7 (43.8%) | .72 |
Cannabis Dependence | 14 (41.2%) | 6 (33.3%) | 8 (50.0%) | Â |
Polysubstance | 1 (2.9%) | 0 (0%) | 1 (6.3%) | .47 |
Age at onset of SUD e , mean ± SD | 13.7 ± 1.2 | 13.8 ± 1.3 | 13.7 ± 1.3 | .86 |
Length of SUD, mean ± SD (weeks) | 117.4 ± 68.7 | 116.0 ± 72.4 | 118.9 ± 66.8 | .91 |